Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease
This study has been completed.
Eisai Co., Ltd.
First Posted: February 27, 2012
Last Update Posted: September 17, 2015
Information provided by (Responsible Party):
Eisai Inc. ( Eisai Co., Ltd. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2015|
|Primary Completion Date:||January 2015 (Final data collection date for primary outcome measure)|